Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 331 AL 345

The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer's disease

Zhang Y, Chen X, Zhao Y, Ponnusamy M, Liu Y.

Rev Neurosci. 2017 Nov 27;28(8):861-868. doi: 10.1515/revneuro-2017-0013.

Current advances in transdermal delivery of drugs for Alzheimer's disease

Nguyen TT, Giau VV, Vo TK.

Indian J Pharmacol. 2017 Mar-Apr;49(2):145-154. doi: 10.4103/0253-7613.208143.

An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds

Zanforlin E, Zagotto G, Ribaudo G.

Curr Med Chem. 2017 Nov 17;24(34):3749-3773. doi: 10.2174/0929867324666170712161829.

[Transmission of pathogenic protein aggregates in Alzheimer's disease]

Schwarzman AL, Sarantseva SV.

Mol Biol (Mosk). 2017 May-Jun;51(3):418-422. doi: 10.7868/S0026898417030144.

Natural product for the treatment of Alzheimer's disease

Bui TT, Nguyen TH.

J Basic Clin Physiol Pharmacol. 2017 Sep 26;28(5):413-423. doi: 10.1515/jbcpp-2016-0147.

Antagonism of the 5-HT(6) receptor - Preclinical rationale for the treatment of Alzheimer's disease

de Jong IEM, Mørk A.

Neuropharmacology. 2017 Oct;125:50-63. doi: 10.1016/j.neuropharm.2017.07.010. Epub 2017 Jul 12.

Amyloid beta: structure, biology and structure-based therapeutic development

Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, Xu HE.

Acta Pharmacol Sin. 2017 Sep;38(9):1205-1235. doi: 10.1038/aps.2017.28. Epub 2017 Jul 17.

Aquaporin 4 in Astrocytes is a Target for Therapy in Alzheimer's Disease

Lan YL, Chen JJ, Hu G, Xu J, Xiao M, Li S.

Curr Pharm Des. 2017;23(33):4948-4957. doi: 10.2174/1381612823666170714144844.

Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core

Lin H, Li Q, Gu K, Zhu J, Jiang X, Chen Y, Sun H.

Curr Top Med Chem. 2017;17(27):3000-3016. doi: 10.2174/1568026617666170717114944.

Mining databases for protein aggregation: a review

Tsiolaki PL, Nastou KC, Hamodrakas SJ, Iconomidou VA.

Amyloid. 2017 Sep;24(3):143-152. doi: 10.1080/13506129.2017.1353966. Epub 2017 Jul 18.

Differences of immune disorders between Alzheimer's disease and breast cancer based on transcriptional regulation

Kong W, Mou X, Deng J, Di B, Zhong R, Wang S, Yang Y, Zeng W.

PLoS One. 2017 Jul 18;12(7):e0180337. doi: 10.1371/journal.pone.0180337. eCollection 2017.

Drug candidates in clinical trials for Alzheimer's disease

Hung SY, Fu WM.

J Biomed Sci. 2017 Jul 19;24(1):47. doi: 10.1186/s12929-017-0355-7.

Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study

Olazarán J, Agüera-Ortiz L, Argimón JM, Reed C, Ciudad A, Andrade P, Dilla T.

Int Psychogeriatr. 2017 Dec;29(12):2081-2093. doi: 10.1017/S1041610217001211. Epub 2017 Jul 19.

Disease Highlights the Cellular Diversity of Neurovascular Units: Sign in Stranger

Faraci FM.

Circ Res. 2017 Jul 21;121(3):203-205. doi: 10.1161/CIRCRESAHA.117.311386.

Transcriptional regulation of APP by apoE: To boldly go where no isoform has gone before: ApoE, APP transcription and AD: Hypothesised mechanisms and existing knowledge gaps

Lee LC, Goh MQL, Koo EH.

Bioessays. 2017 Sep;39(9):10.1002/bies.201700062. doi: 10.1002/bies.201700062. Epub 2017 Jul 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias